Literature DB >> 2557967

Insulin-like growth factor 1 (IGF-1) receptors in the human brain: quantitative autoradiographic localization.

A Adem1, S S Jossan, R d'Argy, P G Gillberg, A Nordberg, B Winblad, V Sara.   

Abstract

The distribution of Insulin-like growth factor 1 (IGF-1) receptors in large cryosections of human brain hemispheres (80-microns) was studied by quantitative autoradiography using 125I-IGF-1 as ligand. Postmortem tissue only from individuals free from neurological diseases was used. The highest densities of IGF-1 receptors were found in the hippocampus, amygdala and parahippocampal gyrus. Intermediate densities were observed in the cerebellum, cerebral cortex and caudate nucleus, whereas low densities of IGF-1 receptors were obtained in the substantia nigra, red nucleus, white matter and cerebral pedunculus. The cartography of IGF-1 receptors in the normal human brain will hopefully be of use in the study of the alteration of these receptors in diseased brain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557967     DOI: 10.1016/0006-8993(89)91678-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  27 in total

1.  Psychiatric and neuropsychological changes in growth hormone-deficient patients after traumatic brain injury in response to growth hormone therapy.

Authors:  N P Maric; M Doknic; D Pavlovic; S Pekic; M Stojanovic; M Jasovic-Gasic; V Popovic
Journal:  J Endocrinol Invest       Date:  2010-05-17       Impact factor: 4.256

2.  Intracerebroventricular insulin-like growth factor-1 decreases feeding in diabetic rats.

Authors:  H Lu; B Martinez-Nieves; K Lapanowski; J Dunbar
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

Review 3.  Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

Authors:  Kawser Akter; Emily A Lanza; Stephen A Martin; Natalie Myronyuk; Melanie Rua; Robert B Raffa
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

4.  Evaluation of depressive mood and cognitive functions in patients with acromegaly under somatostatin analogue therapy.

Authors:  H Alibas; K Uluc; P Kahraman Koytak; M M Uygur; N Tuncer; T Tanridag; D Gogas Yavuz
Journal:  J Endocrinol Invest       Date:  2017-06-28       Impact factor: 4.256

Review 5.  Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support.

Authors:  Samuel E Marsh; Mathew Blurton-Jones
Journal:  Neurochem Int       Date:  2017-02-20       Impact factor: 3.921

Review 6.  The many faces of insulin-like peptide signalling in the brain.

Authors:  Ana M Fernandez; Ignacio Torres-Alemán
Journal:  Nat Rev Neurosci       Date:  2012-03-20       Impact factor: 34.870

7.  Growth hormone treatment in young children with Down's syndrome: effects on growth and psychomotor development.

Authors:  G Annerén; T Tuvemo; C Carlsson-Skwirut; T Lönnerholm; P Bang; V R Sara; J Gustafsson
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 8.  Integration of thermal and osmotic regulation of water homeostasis: the role of TRPV channels.

Authors:  Celia D Sladek; Alan Kim Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

Review 9.  Therapeutic potential of nerve growth factors in Parkinson's disease.

Authors:  T J Collier; C E Sortwell
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

10.  Early-onset GH deficiency results in spatial memory impairment in mid-life and is prevented by GH supplementation.

Authors:  E Nieves-Martinez; W E Sonntag; A Wilson; A Donahue; D P Molina; J Brunso-Bechtold; M M Nicolle
Journal:  J Endocrinol       Date:  2009-10-08       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.